24th Annual Cancer Institute Symposium

Thursday, Oct. 25, 2018

Edward P. Junker III Auditorium
Penn State College of Medicine
700 HMC Crescent Road
Hershey, PA 17033
(No. 27 on our Penn State Health Campus Map)


Select this button to navigate the sections of this page

Conference ID

D6308

Intent

This program is designed to acquaint participants with current trends of basic research and clinical
applications in the field of cancer.

Audience

  • Physicians
  • Physician assistants
  • Nurse practitioners
  • Nurses
  • Laboratory scientists
  • Researchers
  • Residents
  • Graduate students
  • Social and behavioral scientists
  • Patient navigators

Objectives

  • Describe the importance of the tumor microenvironment in influencing the biologic behavior of triple negative breast cancer.
  • Discuss the most recent advances in the treatment of women with triple negative breast cancer.
  • Explore recent developments on immunotherapy of cancer.

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Agenda

7:30 a.m. to Noon

Morning General Sessions

  • 7:30 a.m. | Check-In/Continental Breakfast
  • 8 a.m. | Welcome and Introduction
    Andrea Manni, MD

Session 1: Tumor Immunology and Immunotherapy

Moderator: Todd Schell, PhD

  • 8:15 a.m. | Cell-Based Immunotherapy of Cancer
    Stephen Gottschalk, MD
  • 9 a.m. | Genetic Mechanisms of Immune Evasion in Colorectal Cancer
    Marios Giannakis, MD, PhD
  • 9:45 a.m. | Question-and-Answer Session
  • 10 a.m. | Morning Break

Session 2: Advances in Breast Cancer Research

Moderator: Edward Gunther, MD

  • 10:15 a.m. | Tumor Microenvironment and Triple Negative Breast Cancer (TNBC) Heterogeneity: Clinical Implications
    Morag Park, PhD, FRSC, FCAHS
  • 11 a.m. | Developmental Therapeutics in Triple Negative Breast Cancer (TNBC)
    Funda Meric-Bernstam, MD
  • 11:45 a.m. | Question-and-Answer Session
  • Noon | Lunch/Closing Remarks/Adjournment

Faculty

Penn State Health Milton S. Hershey Medical Center; Penn State College of Medicine; Penn State Cancer Institute; Hershey, PA

Andrea Manni, MD
Professor of Medicine
Chief, Division of Endocrinology Diabetes and Metabolism

Edward Gunther, MD
Professor of Medicine
Member, Jake Gittlen Laboratories for Cancer Research
Division of Hematology-Oncology

Todd Schell, PhD
Professor of Microbiology and Immunology
Faculty Director, Flow Cytometry Core Facility

Invited Faculty

Marios Giannakis, MD, PhD
Instructor in Medicine
Physician, Gastrointestinal Cancer Center
Associate Member, The Broad Institute of M.I.T. and Harvard
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA

Stephen Gottschalk, MD
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
St. Jude Children’s Research Hospital
Memphis, TN

Funda Meric-Bernstam, MD
Chair, Department of Investigational Cancer Therapeutics
Medical Director, Institute for Personalized Cancer Therapy
Nellie B. Connally Chair in Breast Cancer Research
Professor, Divisions of Cancer Medicine and Surgery
The University of Texas MD Anderson
Houston, Texas

Morag Park, PhD, FRSC, FCAHS
Director, Rosalind and Morris Goodman Cancer Centre
Diane and Sal Guerrera Chair in Cancer Genetics
James McGill Professor
Departments Oncology, Biochemistry and Medicine
McGill University
Montreal, Quebec, CA

Fee

There is no fee for this program, but registration is required by Oct. 18, 2018.

The program includes instruction, all listed meals and online handout materials.

Cancellations

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund registration fees but cannot be held responsible for any related costs, charges, or expenses, including cancellation/change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.

Sponsor

This program is a continuing education service of Penn State College of Medicine.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. D6308

Jump to ...